Phase 2 Lung Cancer Trial, Not Yet Recruiting NCT07355231 Sponsor: Xemed LLC Condition: Lung Cancer
Back to Lung Cancer

Phase 2 Lung Cancer Trial, Not Yet Recruiting

NCT07355231
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 or older who have been diagnosed with non-small cell lung cancer and are planned to receive a full course of radiation therapy as their main treatment.
  • People who previously had successful radiation therapy for lung cancer and have since developed a new, separate lung cancer that is planned to be treated with radiation therapy.
  • People with a newly diagnosed lung cancer planned for radiation therapy who also have lung changes caused by existing health conditions, such as advanced chronic obstructive pulmonary disease (COPD, stage 3 or higher).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People under 18 years of age.
  • People who are known to be pregnant, or who test positive on a pregnancy test.
  • People who have any known medical reason why an MRI scan would not be safe for them.
  • People who have any implanted metal device in their body.
  • People who are not able to give informed consent to participate.
  • People who have a language barrier, communication difficulty, cognitive condition, or behavioural condition that could affect their ability to fully and informedly participate in the study.
  • People with a history of organ failure that has not been stabilised through medical treatment (confirm with trial site).
  • People who are experiencing homelessness or an otherwise unstable living situation.
  • People with an active dependence on drugs or alcohol.
  • People who experience claustrophobia (fear of enclosed spaces).
  • People who weigh more than 300 pounds (approximately 136 kilograms).
  • People whose chest size is too large to fit within the MRI machine used in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026

Contact this trial

Phone: 2672999618

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Xemed LLC
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
29 February 2028

Primary endpoints

Changes in DLCO at 6-month post RT treatment.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov